Navigation Links
New insight into aggressive childhood cancer
Date:1/5/2009

A new study reveals critical molecular mechanisms associated with the development and progression of human neuroblastoma, the most common cancer in young children. The research, published by Cell Press in the January 6th issue of the journal Cancer Cell, may lead to development of future strategies for treatment of this aggressive and unpredictable cancer.

Neuroblastoma cells are derived from migratory neural crest cells that give rise to the peripheral sympathetic nervous system. During normal development, neural crest cells stop dividing and differentiate. However, neuroblastoma cells seem to have lost this capacity. Previous work has shown that amplification of the MYCN gene, which disrupts control of cell division and differentiation, is a strong predictor of poor prognosis in neuroblastoma.

"We speculated that genes that are expressed in a MYCN-dependent manner might be required specifically for the growth of MYCN-amplified neuroblastomas and that MYCN-amplified neuroblastomas might depend not only on N-Myc itself, but also on upstream regulatory factors or downstream target genes," explains senior study author, Dr. Martin Eilers, from the University of Wurzburg in Germany.

Dr. Eilers and colleagues performed a genetic screen of nearly 200 genes that are dependent on amplified MYCN in human neuroblastoma or are direct targets of Myc. The researchers found that the oncogene AURKA is required for growth of MYCN-amplified neuroblastoma cells, but not cells lacking amplified MYCN.

AURKA encodes the kinase Aurora A which is dysregulated in multiple types of cancer cells. Interestingly, Aurora A kinase activity was not required for N-Myc stabilization. Instead, elevated Aurora A levels in MYCN-amplified neuroblastoma cells interfered with the PI3-kinase-dependent and mitosis-specific degradation of N-Myc. This suggests that small molecule inhibitors of Aurora A kinase may not be effective at inhibiting the oncogenic fu
'/>"/>

Contact: Cathleen Genova
cgenova@cell.com
617-397-2802
Cell Press
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Analog Devices Healthcare Team Participates in MIT Forum on Medical Device Industry : ADI's healthcare technology experts Patrick O'Doherty and Tom O'Dwyer offer insights on trends impacting next-generation medical electronic systems.
2. Researchers gain new insight on wonder of cell division
3. New Strong Knees DVD Offers Knee Pain Relief from Body Insight, Inc. and Gaiam Inc.
4. Insight deficit may explain denial in drug addiction
5. HIV Vaccine Failure Still Brings Insights
6. Researcher to provide new insight for treating vascular disease
7. Genetic Research Offers Insights Into Form of Malaria
8. New insights could lead to a better pneumococcal vaccine
9. Study offers new insights into teenagers and anxiety disorders
10. Baird Hosts Small Cap Health Care Conference : Senior Healthcare Distribution & Services Research Analyst Eric Coldwell Shares Insights on Sector
11. New Insight Into Most Common Forebrain Malformation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...LY-SUR-SEINE, France, Nov. 27 Team...l cycling team dedicated to ethical sporting and d..., announced today that it will become Team Garmin-...al as a new sponsor of the team. Transitions Optic... eyewear, offering the most advanced photochromic ...
(Date:11/27/2009)....27/PRNewswire/-- Allrecipes.com , theworld,s#1fo...rs,withmorethan2.8millionvisitorsthedaybeforeThank...biggestfoodholidayoftheyear.TheaverageThanksgiving...centincreasefromlastyear,sfeast.AccordingtotheAllr...opularThanksgivingrecipe,acontrastfromlastyear,spo...
(Date:11/26/2009)...K, Nov. 27 With cold and flu seaso... good practices to control the spread of infection...e not only to keep ourselves healthy, but to avoid...Finerty, RN, MS, CIC (certified in infection-contr...cupational health at Hospital for Special Surgery ...
(Date:11/26/2009)...hrill when on an emotional rollercoaster, study fi...s) -- Call it the fear factor meets the jubilant s...rs -- especially those who root for the winning te...osely contested match and victory was in doubt, pr...hew on that this Thanksgiving weekend as you,re gl...
(Date:11/26/2009)... Ennis & Ennis, P.A. is offering free na...az and Yasmin birth control pills who have suffere..., Stroke, Heart Attack or other related cardiac is...all toll free at 1-800-856-6405 or go to the firm&...ill out an online case evaluation form. , ...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3
...o,s residents cross the Texas-Mexico border to Ciu...services, according to a study by researchers at T...Paso Regional campus. , Results from this study ...r purchase of health care and medications from a r...
...maged brain areas did not bring significant reduct...IDAY, Feb. 20 (HealthDay News) -- An experimental...significantly reduce disability in stroke patients...e University of California, San Diego used the Neu...
...eb. 20 Misonix, Inc. (Nasdaq: MSON ), a develop... technology, which in Europe is used for the ablat... conditions, has entered into a new, three year, e...he SonaStar(TM) Ultrasonic Surgical Aspirator and ...
...o destroy bad, not good, E. coli, , , FRID...for new drugs to fight the bacteria that cause man... U.S. researchers. , Two molecules called yersinia... two molecules -- called siderophores -- could he...
... BurrellesLuce Vice President Johna Burke, a p...ment, will be one of the expert panelists discussi...meeting of the National Capital Chapter of the Pub... prominent authority on media monitoring and measu...
...orld Health Organization has designated the Regens... world,s first WHO Collaborating Center for Medica... for the "design, application, and research of med...nnovative use of information technology within med...
Other Medicine News:Health News:Lack of insurance drives El Pasoans across the border for healthcare 2Health News:Laser Therapy Disappoints in Stroke Trial 2Health News:Misonix Announces New Distribution Agreement for Israel 2Health News:Misonix Announces New Distribution Agreement for Israel 3Health News:Finding May Lead to New Drugs for Urinary Infections 2Health News:BurrellesLuce VP Johna Burke Among Measurement Experts To Speak at Feb. 25 Meeting of PRSA's National Capital Chapter 2Health News:BurrellesLuce VP Johna Burke Among Measurement Experts To Speak at Feb. 25 Meeting of PRSA's National Capital Chapter 3Health News:Regenstrief Institute receives World Health Organization designation 2
(Date:11/27/2009)...ON, Minn, Nov. 27 ACUO TECHNOLOGIE...nagement software, data migration tools and servic...Patent and Trademark Office has approved a patent ...hin a Computer Network." Acuo Technologies is plea...ellectual property. In general, the granted patent...
(Date:11/25/2009)...AND, Colo., Nov. 25 Hesk...er of advanced diagnostic and specialty products...ments with Roche Diagnostics Corporation for the s...bles for the veterinary market. ,, (Logo: ...LOGO ) ,, "Heska and Roche share the same passi...
(Date:11/25/2009)...v.25/PRNewswire/--BioTrendsResearchGroup,Inc.relea...t,thefirstinamulti-phasesyndicatedmarketresearchpr...lara,fromproductlaunchthroughthefirstsixmonthsofav...informationfrom75uniqueDermatologistsandqualitativ...nduseofStelara,obstaclestouse,typicalpatienttypes,...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 14938 1Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 14938 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 1Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 5Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 6Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 7Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 8Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 9Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 10QlikTech Wins Healthcare IT Innovation 26amp 3B 238482 3B Award 61914 1QlikTech Wins Healthcare IT Innovation 26amp 3B 238482 3B Award 61914 2QlikTech Wins Healthcare IT Innovation 26amp 3B 238482 3B Award 61914 3QlikTech Wins Healthcare IT Innovation 26amp 3B 238482 3B Award 61914 4
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: